Report Code : CVMI1405202503 | Published Date : May 14, 2025
The Poultry Eubiotics Market is projected to grow from USD 1.8 billion in 2024 to USD 3.4 billion by 2031, at a compound annual growth rate (CAGR) of 8.9%.
- Key Driver: 72 countries now ban antibiotic growth promoters (AGPs)
- Tech Shift: 3rd-gen probiotics show 91% pathogen inhibition
- Hotspot: Brazil's broiler farms achieve 18% FCR improvement
Product Type Breakdown (2024)
|
Eubiotic |
Market Share |
Key Innovation |
|
Probiotics |
38% |
CRISPR-edited Bacillus strains |
|
Organic Acids |
32% |
Microencapsulated butyrates |
|
Phytogenics |
22% |
Standardized oleoresins |
|
Prebiotics |
8% |
FOS-GOS synbiotic blends |
Disease Prevention Efficacy
Top Applications & ROI
- Necrotic Enteritis Control
- DSM's Probiotic-Phage combo: 89% C. perfringens reduction
- ROI: $3.20 saved per bird
- Salmonella Mitigation
- Chr. Hansen's Biosecurity program: 2.1 log reduction
- EU compliance solution for exports
- Mycotoxin Management
- Bentonite-probiotic hybrids: 42% aflatoxin binding
Technology Innovations
- Next-Gen Delivery Systems
- Intestinal-targeted microcapsules (Novozymes)
- Water-soluble postbiotics (Lallemand)
- AI Formulation Tools
- Cargill's NutriOpt: 35% faster strain selection
- Sustainable Production
- Upcycled agricultural byproducts (ADM)
Regulatory Landscape
- EU: 2024 category-specific efficacy requirements
- US: FDA VFD updates for phage products
- China: GB 7300-2023 standard implementation
Competitive Analysis
|
Company |
2024 Share |
Strategic Move |
|
DSM |
25% |
Acquired Novozymes' microbiome assets |
|
Chr. Hansen |
22% |
Launched 3-strain Salmonella solution |
|
Cargill |
18% |
$75M Thailand facility expansion |
|
Lallemand |
12% |
Patented yeast postbiotic tech |
Reasons To Buy
Scope
- Cargill, Incorporated
- BASF SE
- Koninklijke DSM N.V.
- DuPont de Nemours, Inc.
- Chr. Hansen Holding A/S
